Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B
Authors
Keywords
-
Journal
Molecular Oncology
Volume 12, Issue 3, Pages 406-420
Publisher
Wiley
Online
2018-01-23
DOI
10.1002/1878-0261.12174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
- (2017) Martin J van den Bent et al. LANCET
- Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
- (2017) Tyler E. Miller et al. NATURE
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL
- (2017) Ibrahim Cagri Kurt et al. Cell Death & Disease
- Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with Metformin
- (2016) HIKARU WATARAI et al. ANTICANCER RESEARCH
- Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis
- (2016) Jaclyn Andricovich et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer stem cells
- (2016) Jeremy N. Rich MEDICINE
- An epigenetic gateway to brain tumor cell identity
- (2016) Stephen C Mack et al. NATURE NEUROSCIENCE
- Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
- (2016) S Ramadoss et al. ONCOGENE
- Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
- (2016) Mikkel Staberg et al. CELLULAR ONCOLOGY
- Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2
- (2015) T. Ueda et al. BLOOD
- The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
- (2015) Barbara Banelli et al. CELL CYCLE
- Advances in the development of histone lysine demethylase inhibitors
- (2015) Tamara Maes et al. CURRENT OPINION IN PHARMACOLOGY
- Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation
- (2015) Yuhui Jiang et al. NATURE CELL BIOLOGY
- Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma
- (2015) Stefano Amente et al. Oncotarget
- Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21
- (2014) Bin Dai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells
- (2014) F. Kottakis et al. CANCER RESEARCH
- The FBXL10/KDM2B Scaffolding Protein Associates with Novel Polycomb Repressive Complex-1 to Regulate Adipogenesis
- (2014) Takeshi Inagaki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- Inhibition of demethylases by GSK-J1/J4
- (2014) Bo Heinemann et al. NATURE
- Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
- (2014) Rintaro Hashizume et al. NATURE MEDICINE
- The KDM2B- Let-7b -EZH2 Axis in Myelodysplastic Syndromes as a Target for Combined Epigenetic Therapy
- (2014) Ekapun Karoopongse et al. PLoS One
- The histone LSD1 demethylase in stemness and cancer transcription programs
- (2013) Stefano Amente et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Chromatin Remodeling at DNA Double-Strand Breaks
- (2013) Brendan D. Price et al. CELL
- KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors
- (2013) Joshua C. Black et al. CELL
- Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes
- (2013) Jin He et al. NATURE CELL BIOLOGY
- Histone lysine demethylases as targets for anticancer therapy
- (2013) Jonas W. Højfeldt et al. NATURE REVIEWS DRUG DISCOVERY
- Is Glioblastoma an Epigenetic Malignancy?
- (2013) Marta Maleszewska et al. Cancers
- Epigenetics in human gliomas
- (2012) Simone Kreth et al. CANCER LETTERS
- Histone Demethylase KDM5B Collaborates with TFAP2C and Myc To Repress the Cell Cycle Inhibitor p21cip (CDKN1A)
- (2012) P.-P. Wong et al. MOLECULAR AND CELLULAR BIOLOGY
- Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
- (2012) Joshua C. Black et al. MOLECULAR CELL
- The role of histone demethylases in cancer therapy
- (2012) Inga Hoffmann et al. Molecular Oncology
- Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming
- (2012) Gaoyang Liang et al. NATURE CELL BIOLOGY
- KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands
- (2012) Anca M Farcas et al. eLife
- KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia
- (2011) J. He et al. BLOOD
- Lysine-specific Demethylase 2B (KDM2B)-let-7-Enhancer of Zester Homolog 2 (EZH2) Pathway Regulates Cell Cycle Progression and Senescence in Primary Cells
- (2011) Alexandros Tzatsos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BMI1 Is Recruited to DNA Breaks and Contributes to DNA Damage-Induced H2A Ubiquitination and Repair
- (2011) V. Ginjala et al. MOLECULAR AND CELLULAR BIOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
- (2010) Shinya Hayami et al. INTERNATIONAL JOURNAL OF CANCER
- Histone demethylases in development and disease
- (2010) Marianne Terndrup Pedersen et al. TRENDS IN CELL BIOLOGY
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing theInk4a/Arflocus
- (2009) Alexandros Tzatsos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15Ink4b
- (2008) Jin He et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started